The GC is the anatomical site where antigen-activated B cells differentiate into PC, producing high-affinity antibodies in physiological and pathological states. PC differentiation is regulated by multiple factors within the GC microenvironment, including cytokines. IL-21, a recently identified type I cytokine produced by GC-Th cells, promotes differentiation of human B cells into ISC. In this study, we investigated in detail the functional role of IL-21 in the course of GC-B cell differentiation into terminally differentiated PC compared with that of IL-10, a well-known PC differentiation factor. IL-21 had a greater capacity to initiate PC differentiation from CD77 ϩ centroblasts than IL-10 by strongly inducing PC transcription factors through activation of STAT3; however, IL-10 was more potent than IL-21 in generating CD138
Introduction
Long-lived memory B cells and PC form the cellular basis for sustaining antibody-mediated immunity [1, 2] . PC are crucial immune effector cells that produce protective antibodies; however, uncontrolled generation of antibodies results in multiple tissue destruction, as shown in autoimmune disease [3] . Although short-lived PC arise rapidly in the secondary lymphoid organs, allowing for immediate production of protective antibodies to acute infections, long-lived PC arise weeks after antigen exposure within the GC of lymphoid follicles and then exit the GC and migrate to the bone marrow, where they reside as long-lived PC that produce antibodies for long periods of time [2, 4 -6] .
The GC is a specialized microenvironment where antigen-activated B cells undergo clonal expansion, somatic hypermutation, Ig class-switch recombination, and differentiation into memory B cells or high-affinity antibody-secreting PC [7] [8] [9] . These cellular and genetic events occur through interactions of antigen-activated B cells with FDC and T cells, which have essential but distinct, functional roles in GC-B cell differentiation. Although FDC protect GC-B cells from apoptosis and support proliferation by providing FDC-signaling molecules [10] , T cells induce GC-B cell differentiation by providing CD40L and cytokines. T cell cytokines determine the pathway of GC-B cell differentiation [11] [12] [13] . IL-4 directs GC-B cells into memory B cells, whereas IL-10 steers them toward PC. IL-2 does not determine the differentiation pathways but synergizes with IL-4 or IL-10 to augment cellular expansion of memory B cells and PC.
Recently, IL-21 has been recognized as a potent PC differentiation factor for human B cells. IL-21 induces ISC rapidly from naïve, memory, and GC-B cells [14 -16] . Although the effect of IL-21 on the differentiation of human naïve and memory B cells was studied extensively, that of IL-21 on the differentiation of GC-B cells has not been studied in detail, despite GC-B cells contributing to long-term antibody response by generating mostly IgG-secreting, long-lived PC. Although Bryant et al. [16] reported that IL-21 predominantly induced GC-B cell differentiation into ISC, the study only showed early events in PC differentiation by culturing GC-B cells for 4 days in vitro. GC-B cells could not be cultured for longer than 4 days as a result of their propensity for apoptosis [17] [18] [19] . However, it is known that FDC or FDC lines can prevent apoptosis of GC-B cells [18, 20, 21] . To analyze the effect of IL-21 in the GC-B cell differentiation to long-lived, terminally differentiated PC, we adopted a unique in vitro culture system that mimics the in vivo GC microenvironment by including a FDC line, HK [12, 19] . As this culture condition allowed GC-B cell survival and proliferation for longer than 14 days [12, 13, 22] , we were able to generate terminally differentiated CD138
ϩ PC from GC-B cells and investigate the effects of IL-21 on the later stage of PC differentiation (i.e., plasmablasts to long-lived, terminally differentiated PC) as well as the early stage, comparing with those of IL-10.
Here, we show that IL-21 and IL-10 have redundant roles but differential capacities at each stage of PC development from GC-B cells. IL-21 is more potent than IL-10 in committing CD77 ϩ centroblasts to CD20 -
CD38
ϩϩ plasmablasts in the early stage, and IL-10 has a greater capacity in the later stage to produce terminally differentiated CD138
ϩ PC from CD20 -CD38 ϩϩ plasmablasts.
MATERIALS AND METHODS

Antibodies
Antibodies used in this work were anti-CD77, PE-conjugated anti-CD138, anti-IL-2R␣, PerCP-conjugated anti-CD20, APC-conjugated anti-CD38, and 
Cytokines and reagents
Cytokines used were IL-2 (Hoffman-La Roche, Nutley, NJ, USA), IL-10 (R&D Systems), and IL-21 (Biovision, Mountain View, CA, USA). Dr. Richard Armitage (Amgen Corp., Seattle, WA, USA) generously provided soluble human CD40L.
Preparation and culture of B cell subsets
CD77 ϩ centroblasts were isolated from tonsillar B cells using a MACS column. CD77 ϩ centroblasts (2ϫ10 5 cells/well) were cultured in 24-well plates in the presence of irradiated HK cells (2ϫ10 4 cells/well; 5000 rad), CD40L (100 ng/ml), IL-21 (10 ng/ml), IL-10 (50 ng/ml), IL-2 (30 U/ml), or a combination of the cytokines. The culture medium was IMDM (Irvine Scientific, Santa Ana, CA, USA), supplemented with 10% FCS (Life Technologies, Grand Island, NY, USA), 2 mM glutamine, 100 U/ml penicillin G, and 100 g/ml streptomycin (Irvine Scientific). An optimum dose of IL-10 and IL-21 was used in the study, which was determined by a GC-B cell growth assay, as shown in Supplemental Figure 1 . 
Flow cytometry and ELISA
Cells were stained with a panel of mAb, unconjugated or conjugated directly with PE, PerCP, or APC, as described previously [19] . Briefly, cells were incubated with the appropriate concentration of mAb for 15 min at 4°C. Unconjugated mAb were detected by FITC-labeled goat anti-mouse Ig. After washing with PBS containing 0.2% BSA and 0.1% sodium azide, cells were fixed with 1% paraformaldehyde and analyzed by flow cytometry. Ct values were analyzed with the ⌬⌬Ct method by using ␤2 microglobulin expression for normalization in each experiment. Data from four different donors were pooled, and results were expressed as fold change with respect to that of CD77 ϩ centroblasts at Day 0 and plotted in Graphpad 
Statistical analysis
Statistical analysis and graphic presentation were carried out with GraphPad Prism 4.0 (GraphPad Software). Results are presented as means of triplicate assays plus sem. The statistical significance of differences was determined by Student's t-test; P Ͻ 0.05 was considered significant.
RESULTS
IL-21 and IL-2/IL-10 generate long-lived, terminally differentiated PC from CD77 ؉ centroblasts in longterm culture
To explore the effects of IL-21 precisely on GC-B cell differentiation, CD77
ϩ centroblasts were isolated from tonsillar B cells, as CD77 -cells contain heterogeneous populations of centroblasts, centrocytes, and plasmablasts [23] . Purified CD77 ϩ centroblasts (Ͼ95%) were cultured with IL-21 or a combination of IL-2 and IL-10 (IL-2/IL-10) in the presence of HK cells and CD40L for up to 10 days. IL-2/IL-10 was used to compare the effect with IL-21, as IL-2/IL-10 is more potent in the generation of ISC from GC-B cells than IL-10 alone [19] .
During the culture period, total viable cell number and antibody secretion increased progressively (Fig. 1, A and B) . In particular, cell growth and antibody production between Days 4 and 7 increased exponentially, which could not be achieved in conventional culture, where FDC are absent. To analyze the phenotypic changes in different stages of PC generation, cells were collected from cultures at Days 0, 4, 7, and 10 ( Fig. 1C) 
IL-21 enhances proliferation of CD77
؉ centroblasts and generation of plasmablasts greater than IL-10
Differentiation of CD77
ϩ centroblasts into terminally differentiated CD138
ϩ PC is a multistep process. As shown above (Fig.  1C) First, we examined the effect of these two cytokines on CD77 ϩ centroblasts in the early stage of PC differentiation by culturing CD77 ϩ cells for 3 days (Fig. 2) . Although recovery of the cells cultured in the absence of cytokines (control culture) was ϳ54%, the addition of IL-21 increased the cell number 3.4-fold over the control culture ( Fig. 2A) . IL-10 also increased the viable cell number but to a lesser extent (1.5ϫ over the control culture). The addition of IL-2 to the culture containing IL-21 did not enhance the cell recovery further, whereas the addition of IL-2-to-IL-10-containing culture increased the cell number as observed previously [19] . The increase in cell number by IL-21 and IL-2/ IL-10 appears to be a result of rapid cell division, as neither cytokines increased GC-B cell survival (Fig. 2B) . At this time-point, the majority of cells generated in the culture was non Ig-secreting CD20 ϩ CD38 Ϯ preplasmablasts similar to the phenotype observed on Day 4 (Fig. 1C) . However, a small percentage of cells (6 -15%) were Ig-secreting CD20 -
CD38
ϩϩ plasmablasts (Fig. 2C) . As the number of CD20 -CD38 ϩϩ plasmablasts was computed from the percentage and viable cell number, IL-21 generated more CD20 -
ϩϩ plasmablasts than IL-10 ( Fig. 2D) . It is of notice that IL-2 had a synergistic effect with IL-21 and IL-10 on generation of CD20 -CD38 ϩϩ plasmablasts. The increase of CD20 -CD38 ϩϩ plasmablasts was confirmed by the proportional increase of IgG secretion in the supernatants (Fig.  2E) . The data suggest that IL-21 induces CD77 ϩ centroblasts to Ig-secreting CD20 -CD38 ϩϩ plasmablasts greater than IL-10.
IL-21 and IL-2/IL-10 initiate PC differentiation by regulating PC-specific transcription factors
As commitment of B cells to PC lineage cells is driven by specific transcription factors [24] , the differential effects of IL-21 and IL-2/IL-10 on PC generation were examined further by the expression of transcription factors crucial for B cell differentiation using real-time PCR. As shown in -CD38 ϩϩ plasmablasts generated (C), the absolute number of CD20 -CD38 ϩϩ plasmablasts (D), and IgG concentration (E) were determined. For apoptosis assay, CD77 ϩ centroblasts were cultured as indicated for 24 h, and Annexin V-FITC and PI binding were measured by flow cytomerty (B). Shown is representative of three reproducible experiments (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001). L, CD40L; NS, not significant; ND, not determined because of lack of cells.
IL-21 has a greater capacity to induce expression of Blimp-1 and the subsequent XBP-1s, which is essential for antibody secretion [25] .
As STAT3 activation triggers B cell differentiation into PC by inducing Blimp-1 expression [26] , we examined STAT3 activation by IL-21 and IL-2/IL-10 (Fig. 3B) . IL-21 phosphorylated STAT3 significantly more than did IL-2/IL-10 at all timepoints examined. There was no detectable phosphorylation of STAT3 before the cells were stimulated by IL-21 or IL-2/IL-10.
IL-10 has a greater capacity than IL-21 in generating terminally differentiated CD138
؉ PC from CD20 -CD38
؉؉ plasmablasts
Although IL-21 induced plasmablasts from CD77 ϩ centroblasts greater than IL-10 in the first 3 days of the culture, we speculated whether IL-21 was more potent than IL-10 in differentiating CD20 -CD38 ϩϩ plasmablasts into terminally differentiated CD138 ϩ PC. To address this question, CD20 -CD38 ϩϩ plasmablasts were isolated following the culture of CD77 ϩ centroblasts with IL-21 for 5 days and then cultured for an additional 3 days with HK cells and different cytokines. In the second culture, CD40L was omitted to accelerate PC differentiation [19, 27] .
Unlike the results obtained in the culture of CD77 ϩ centroblasts (Fig. 2) , the cell recovery was low (85-175% of the initially seeded numbers with cytokines; Fig. 4A ), and antibody secretion was high (Fig. 4C) , consistent with characteristic of mature PC subsets. There was no significant difference in cell recovery between IL-21 and IL-10, although IL-21 increased the cell number consistently more than IL-10. However, IL-10 enhanced the generation of terminally differentiated CD138
ϩ PC significantly compared with IL-21 (53% vs. 28%; Fig. 4B ). At the same time, IgG in the supernatant of the culture with IL-10 was significantly higher than that in the culture with IL-21 (Fig. 4C) . The amounts of the secreted IgG correlated with absolute numbers of terminally differentiated CD138 ϩ PC generated (Fig. 4D ). The addition of IL-2 to the culture with IL-10 or IL-21 did not increase CD138
ϩ PC percentage and IgG production further. The data suggest that IL-10 is more effective than IL-21 in generating terminally differentiated PC from plasmablasts.
Cytokine receptors are modulated during PC differentiation from CD77
؉ centroblasts
As the effects of IL-21 and IL-10 were significantly different depending on B cell subsets, we next investigated whether this difference was attributed to a differential expression of receptors (IL-21R and IL-10R; Fig. 5A ). Moderate and homogeneous expression of IL-21R was detected on CD77 ϩ centroblasts at Day 0, but the expression was down-regulated in CD20 -CD38 ϩϩ plasmablasts, generated following the culture of CD77
ϩ centroblasts with IL-21 for 5 days. In contrast, IL-10R was up-regulated in CD20 -CD38 ϩϩ plasmablasts. At the same time, IL-2R expression was up-regulated significantly, as reported previously [16] . This phenomenon was observed consistently in two independent experiments using two different donors, suggesting that expression of cytokine receptors (IL-21R and IL-10R) is modulated in the course of PC differentiation, affecting cellular response to each cytokine.
This result was confirmed further by the downstream signaling pathway, STAT3 activation, as shown in Figure 5B . Western blot analysis of the tyrosine phosphorylation status of STAT3 molecules in CD20 -
CD38
ϩϩ plasmablasts revealed that IL-21 and IL-2/IL-10 could activate STAT3 as early as 5 min, and the activation was sustained for 30 min. However, the activation of STAT3 by IL-2/IL-10 was stronger than IL-21 at a later time-point (30 min; Fig. 5B ).
Taken together, the differential effects of IL-21 and IL-10 on CD77
ϩ centroblasts and CD20 -CD38 ϩϩ plasmablasts were reflected in cytokine receptor expression. Furthermore, the effects of both cytokines were exerted by STAT3 activation but quantitatively controlled.
DISCUSSION
The generation of long-lived PC in the GC is a multistep process that involves the commitment of B cells to PC precursors and expansion, proliferation, and differentiation into Ig-secreting PC [24] . However, the functional roles of T cell cytokines in the generation of long-lived PC from GC-B cells are not clear, as GC-B cells could not be cultured for longer than 3-4 days in a conventional culture system without FDC [17] [18] [19] . Thus, we took advantage of our unique in vitro experimental model, where GC-B cells could be cultured for longer than 14 days by including a FDC line, HK cells [12, 22] . Using this system, we were able to generate fully differentiated CD138
ϩ IgGsecreting PC from tonsillar CD77 ϩ centroblasts for the first time. Besides rescuing GC-B cells from apoptosis, FDC/HK cells are likely to contribute to the differentiation of GC-B cells to terminally differentiated PC by providing extrinsic microenvironmental factors, as FDC/HK cells produce an array of cytokines and differentiation factors [10, 28, 29] . Hence, our culture system allowed us to compare the effects of two PC differentiation cytokines, IL-21 and IL-10, on CD77 ϩ centroblasts, as well as CD20 -CD38 ϩϩ plasmablasts, emerging in the course of GC-B cell differentiation to mature PC.
IL-21 has significantly dominant effects in the early stage of PC differentiation, as shown in culture for 3-4 days, compared with IL-10 or IL-2/IL-10. Consistent with the previous observation [30] , IL-21 enhanced GC-B cell recovery better than IL-10. The increased cell recovery with IL-21 or IL-2/IL-10 appeared to be attributed to cellular proliferation, as these cytokines did not increase the survival of centroblasts. CD77 ϩ centroblasts cultured with IL-21 produced higher amounts of antibody compared with the cells grown with IL-10. The difference between IL-21 and IL-10 in antibody production resulted from the difference in their capacity to generate Ig-secreting CD20 -CD38 ϩϩ plasmablasts from CD77 ϩ centroblasts. This differential capacity to induce PC differentiation was confirmed by modulation of transcription factors that coordinately drive terminal differentiation of B cells [24] . When CD77 ϩ centroblasts were cultured with IL-21 for 3 days, the expression of Blimp-1 and XBP-1s was significantly higher than those of IL-2/IL-10 (7.4-and 7.7-fold, respectively). As Blimp-1 and XBP-1s are required for commitment to the PC lineage and secretion of antibody [24, 25] , increased antibody secretion by IL-21, compared with IL-10 or IL-2/IL-10, can be explained by the remarkable increase of Blimp-1 and XBP-1s. At the same time, both cytokines decreased the expression of Pax-5 and Bcl-6 significantly, which are known to be switched off before PC differentiation [31, 32] . Although IL-21 has been shown to induce Bcl-6 in some B cell subsets [26, 33, 34] , the decrease in Bcl-6 expression appeared to be necessary for PC differentiation in GC-B cells, which express Bcl-6 at the highest levels among B cell subsets [35, 36] . Our conclusion was supported by the observation that Bcl-6 expression dropped dramatically in 24 h when GC-B cells were cultured with IL-2/IL-10 [22] . The data suggest that down-regulation of Bcl-6 and Pax-5 is followed by up-regulation of Blimp-1 and XBP-1s. The dramatic modulation of the PC transcription factors was also reflected by STAT3 phosphorylation, which is consistent with the recent report that STAT3 activation triggers B cell differentiation into PC by inducing Blimp-1 expression [26] .
In contrast to the greater capacity of IL-21 in committing CD77 ϩ centroblasts to Ig-secreting PC lineage, the effect of IL-10 was more potent than IL-21 in generating terminally differentiated CD138
ϩ PC from CD20 -CD38 ϩϩ plasmablasts and antibody production. This differential effect of IL-21 and IL-10 was reflected in receptor expression on B cell subsets emerging in the course of differentiation. The expression of IL-21R on CD77 ϩ centroblasts was down-regulated at the stage of CD20 -CD38 ϩϩ plasmablasts, and IL-10R was up-regulated, suggesting that B cell subsets at various differentiation stages use different cytokines strategically by regulating the expression of cytokine receptors. The differential effects of two cytokines were substantiated further by the sequential activation of STAT3 in response to cytokines. At the same time, the potential indirect effect of these cytokines through FDC/HK cells is ruled out, as FDC/HK cells express neither IL-21R nor IL-10R (data not shown). Taken together, our data suggest that IL-21 and IL-10 have redundant but differential roles at different stages of PC development to elicit productive and appropriate humoral immunity.
As summarized in Figure 6 , we hypothesize that IL-21 is essential for rapid antibody production against acute infection by inducing ISC rapidly, and IL-10 is associated with a long-term, steady antibody response observed in vaccination and chronic autoimmune diseases by generating terminally differentiated CD138 ϩ PC. Indeed, naïve B cells, which provide an initial response to pathogens by producing antibodies rapidly [37, 38] , appear to be dependent strictly on the presence of IL-21 to induce ISC and produce antibodies, as IL-10 or IL-2/IL-10 hardly induces the differentiation of naïve B cells into ISC [14, 39, 40] . In contrast, memory B cells, which acquire a high-affinity, antigen-specific BCR following GC reaction and differentiate rapidly into ISC upon a secondary encounter with antigens [41] , are less dependent on IL-21 for antibody production [14, 15] . The distinct roles of IL-21 and IL-10 are likely to play in vivo, given the facts that availability of GC-Th cells that produce these cytokines is limited, as shown in recent studies using dynamic-imaging analysis [42, 43] , and their capacity of producing cytokines might be another limiting factor. In particular, IL-21 expression is regulated tightly, and IL-10 is produced more abundantly [44 -48] .
Therefore, IL-21 and IL-10 must have the unique capacity to regulate antibody responses and be delivered precisely to where they are needed.
The differential capacity of IL-21 and IL-10 at different stages of PC differentiation suggests that both cytokines should be considered for treating immunodeficiency or autoimmune diseases. X-linked lymphoproliferative disease, an often fatal immunodeficiency, where B cells are present but fail to secrete antibody, can be overcome partially in vitro by IL-10 [49] . Thus, it is possible that IL-21 and IL-10 might restore antibody production more efficiently in these patients. Conversely, targeting IL-21 and IL-10 with antagonists may be a potent candidate for treating autoimmune diseases. Indeed, it has been reported that expression of IL-10, IL-21, or both was increased in several animal models of systemic lupus erythematosus [33, 50, 51] , and the depletion of IL-10 or IL-21 delayed the onset of disease or alleviated the disease process [52, 53] . However, depletion of IL-10 and IL-21 has not been tried but may be a more efficient treatment. It is also possible that the effects of IL-21 and IL-10 may be specific to certain stages of the disease, as shown in GC-B cell differentiation. IL-21 might be an initiating factor to induce PC differentiation, and IL-10 might be an accelerating factor by generating long-lived CD138 ϩ PC and subsequently producing high levels of autoantibodies. Hence, these cytokines would provide a provocative target for novel, immunosuppressive therapies.
